LSTA Q2 2020 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

LSTALisata Therapeutics, Inc.

$44M

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$4M

Net Income

$7M

EPS (Diluted)

$7.50

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

$5M

Free Cash Flow

$4M

Stock-Based Comp.

$294,000

Balance Sheet

Total Assets

$37M

Total Liabilities

$4M

Stockholders' Equity

$34M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$4M	-$5M	+19.7%
Net Income	$7M	-$5M	+228.4%